Corneal Biomechanics During Pregnancy (CorvisPreg)

June 18, 2020 updated by: University of Zurich

Change in Corneal Biomechanics During Pregnancy

It is known that intraocular pressure changes during pregnancy. Collagen structure changes during pregnancy to enable softening of the symphysis, whitening of the birth chanel, and, thus, ultimately to enable delivery of a child. The cornea consists of highly structured collagen fibers. Hence, it seams logically that corneal biomechanics also change during pregnancy.

Study Overview

Status

Unknown

Conditions

Detailed Description

It is known that intraocular pressure changes during pregnancy. Collagen structure changes during pregnancy to enable softening of the symphysis, whitening of the birth chanel, and, thus, ultimately to enable delivery of a child. The cornea consists of highly structured collagen fibers. Hence, it seams logically that corneal biomechanics also change during pregnancy.

Measurement of intraocular pressure is highly dependant on corneal properties. With the Corvis ST device by Ocular Inc. it is possible to measure intraocular pressure and investigated corneal biomechanics. The aim of this study is therefore to compare corneal biomechanical properties during the third trimester with corneal biomechanical properties at 3 months after delivery.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • ZH
      • Zurich, ZH, Switzerland, 8091
        • Recruiting
        • Department of Ophthalmology
        • Contact:
          • Marc Toeteberg-Harms, MD, FEBO
          • Phone Number: +41442558794 +41 44 255 - 1111
          • Email: marc.toeteberg@usz.ch
        • Principal Investigator:
          • Marc Toeteberg-Harms, MD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 38 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

healthy pregnant women with uncomplicated singleton pregnancy

Description

Inclusion Criteria:

  • females
  • pregnant
  • age 18 to 38 yo
  • uncomplicated singleton pregnancy

Exclusion Criteria:

  • any history of ocular disease or surgery other than conjunctivitis, especially no history of glaucoma or corneal disease
  • systemic diseases, i.e. diabetes, hypertension, collagenase
  • current contact lens wear
  • before pregnancy taking any systemic or ocular medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pregnant women
Pregnant woman, age 18 to 38 yo, with uncomplicated singleton pregnancy and no ocular diseases.
Corneal Properties will be measurement with the non-contact Corvis ST Air-Puff Tonometer by Oculus Inc.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Deformation Amplitude
Time Frame: at 3 month post delivery compared to during third trimester
Change in Deformation Amplitude (in millimeters) at 3 month post delivery compared to during third trimester will be assessed.
at 3 month post delivery compared to during third trimester
Change in Applanation Length
Time Frame: at 3 month post delivery compared to during third trimester of the pregnancy
Change in Applanation Length (in millimeters) at 3 month post delivery compared to during third trimester of the pregnancy will be assessed.
at 3 month post delivery compared to during third trimester of the pregnancy
Change in Corneal Velocity
Time Frame: at 3 month post delivery compared to during third trimester of the pregnancy
Change in Corneal Velocity (in meters/second) at 3 month post delivery compared to during third trimester of the pregnancy will be assessed.
at 3 month post delivery compared to during third trimester of the pregnancy
Change in corneal thickness
Time Frame: at 3 month post delivery compared to during third trimester of the pregnancy
Change in corneal thickness (in millimeters) at 3 month post delivery compared to during third trimester of the pregnancy will be assessed.
at 3 month post delivery compared to during third trimester of the pregnancy
Change in Intraocular pressure
Time Frame: at 3 month post delivery compared to during third trimester of the pregnancy
Change in intraocular pressure (in millimeters of mercury, mmHg) at 3 month post delivery compared to during third trimester of the pregnancy will be assessed.
at 3 month post delivery compared to during third trimester of the pregnancy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marc Toeteberg-Harms, MD, FEBO, University Hospital Zurich, Dpt. of Ophthalmology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Anticipated)

December 31, 2020

Study Completion (Anticipated)

January 31, 2021

Study Registration Dates

First Submitted

June 11, 2020

First Submitted That Met QC Criteria

June 11, 2020

First Posted (Actual)

June 16, 2020

Study Record Updates

Last Update Posted (Actual)

June 22, 2020

Last Update Submitted That Met QC Criteria

June 18, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • CorvisPreg

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Non-Contact measurement of corneal properties

Subscribe